{"id":"https://openalex.org/W4407930196","doi":"https://doi.org/10.1016/j.cpan.2025.01.005","title":"Impurity profiling and forced degradation studies of angiotensin (AT1) blockers: A review","display_name":"Impurity profiling and forced degradation studies of angiotensin (AT1) blockers: A review","publication_year":2025,"publication_date":"2025-02-25","ids":{"openalex":"https://openalex.org/W4407930196","doi":"https://doi.org/10.1016/j.cpan.2025.01.005"},"language":"en","primary_location":{"id":"doi:10.1016/j.cpan.2025.01.005","doi":"https://doi.org/10.1016/j.cpan.2025.01.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.cpan.2025.01.005","pdf_url":null,"source":{"id":"https://openalex.org/S202974686","display_name":"Current Pharmaceutical Analysis","issn_l":"1573-4129","issn":["1573-4129","1875-676X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.cpan.2025.01.005","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079256400","display_name":"Ramanlal N. Kachave","orcid":"https://orcid.org/0000-0002-9225-5881","observed_orcids":["https://orcid.org/0000-0002-9225-5881"]},"institutions":[{"id":"https://openalex.org/I4405266106","display_name":"Gokhale Education Society","ror":"https://ror.org/00by8r054","country_code":"IN","type":"other","lineage":["https://openalex.org/I4405266106"]},{"id":"https://openalex.org/I878213199","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731","country_code":"IN","type":"education","lineage":["https://openalex.org/I878213199"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Ramanlal N. Kachave","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India"],"raw_orcid":"https://orcid.org/0000-0002-9225-5881","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India","institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Deepali D. Bhandari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266106","display_name":"Gokhale Education Society","ror":"https://ror.org/00by8r054","country_code":"IN","type":"other","lineage":["https://openalex.org/I4405266106"]},{"id":"https://openalex.org/I878213199","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731","country_code":"IN","type":"education","lineage":["https://openalex.org/I878213199"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Deepali D. Bhandari","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India","institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013087712","display_name":"Prashant Pingale","orcid":"https://orcid.org/0000-0002-5060-3251","observed_orcids":["https://orcid.org/0000-0002-5060-3251"]},"institutions":[{"id":"https://openalex.org/I4405266106","display_name":"Gokhale Education Society","ror":"https://ror.org/00by8r054","country_code":"IN","type":"other","lineage":["https://openalex.org/I4405266106"]},{"id":"https://openalex.org/I878213199","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731","country_code":"IN","type":"education","lineage":["https://openalex.org/I878213199"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Prashant L. Pingale","raw_affiliation_strings":["Department of Pharmaceutics, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India","institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005546476","display_name":"Dattatraya Manohar Shinkar","orcid":"https://orcid.org/0000-0002-7269-3905","observed_orcids":["https://orcid.org/0000-0002-7269-3905"]},"institutions":[{"id":"https://openalex.org/I4405266106","display_name":"Gokhale Education Society","ror":"https://ror.org/00by8r054","country_code":"IN","type":"other","lineage":["https://openalex.org/I4405266106"]},{"id":"https://openalex.org/I878213199","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731","country_code":"IN","type":"education","lineage":["https://openalex.org/I878213199"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dattatraya M. Shinkar","raw_affiliation_strings":["Department of Pharmaceutics, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India","institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066650879","display_name":"Sunil Vishwanath Amrutkar","orcid":"https://orcid.org/0000-0001-7292-5780","observed_orcids":["https://orcid.org/0000-0001-7292-5780"]},"institutions":[{"id":"https://openalex.org/I4405266106","display_name":"Gokhale Education Society","ror":"https://ror.org/00by8r054","country_code":"IN","type":"other","lineage":["https://openalex.org/I4405266106"]},{"id":"https://openalex.org/I878213199","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731","country_code":"IN","type":"education","lineage":["https://openalex.org/I878213199"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sunil V. Amrutkar","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Affiliated Savitribai Phule Pune University, Gokhale Education Society\u2019s, Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik, Maharashtra 422005, India","institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079256400"],"corresponding_institution_ids":["https://openalex.org/I4405266106","https://openalex.org/I878213199"],"apc_list":{"value":2100,"currency":"USD","value_usd":2100},"apc_paid":{"value":2100,"currency":"USD","value_usd":2100},"fwci":1.3514,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.74875436,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"21","issue":"3","first_page":"128","last_page":"144"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.972000002861023},{"id":"https://openalex.org/keywords/impurity-profiling","display_name":"impurity profiling","score":0.984000027179718},{"id":"https://openalex.org/keywords/forced-degradation","display_name":"forced degradation","score":0.968999981880188},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.7879999876022339},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":1.0},{"id":"https://openalex.org/keywords/olmesartan","display_name":"olmesartan","score":1.0},{"id":"https://openalex.org/keywords/degradation-products","display_name":"degradation products","score":0.6729999780654907},{"id":"https://openalex.org/keywords/uplc-ms-ms","display_name":"UPLC-MS/MS","score":0.8090000152587891},{"id":"https://openalex.org/keywords/hplc-nmr","display_name":"HPLC-NMR","score":0.6949999928474426},{"id":"https://openalex.org/keywords/supercritical-fluid-extraction","display_name":"supercritical fluid extraction","score":0.949999988079071},{"id":"https://openalex.org/keywords/ftir-spectroscopy","display_name":"FTIR spectroscopy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/elemental-impurities","display_name":"elemental impurities","score":0.6499999761581421},{"id":"https://openalex.org/keywords/inorganic-impurities","display_name":"inorganic impurities","score":0.8500000238418579},{"id":"https://openalex.org/keywords/organic-impurities","display_name":"organic impurities","score":0.8899999856948853},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9258638620376587},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.6517772674560547},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.5435343980789185},{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.5363997220993042},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.4803939461708069},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.45812734961509705},{"id":"https://openalex.org/C2777682752","wikidata":"https://www.wikidata.org/wiki/Q8564473","display_name":"Forced degradation","level":4,"score":0.4261144995689392},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3634260296821594},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11290422081947327},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09255620837211609},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06981444358825684},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.048834770917892456},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C2775986502","wikidata":"https://www.wikidata.org/wiki/Q420466","display_name":"Ammonium formate","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.cpan.2025.01.005","doi":"https://doi.org/10.1016/j.cpan.2025.01.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.cpan.2025.01.005","pdf_url":null,"source":{"id":"https://openalex.org/S202974686","display_name":"Current Pharmaceutical Analysis","issn_l":"1573-4129","issn":["1573-4129","1875-676X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Analysis","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.cpan.2025.01.005","doi":"https://doi.org/10.1016/j.cpan.2025.01.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.cpan.2025.01.005","pdf_url":null,"source":{"id":"https://openalex.org/S202974686","display_name":"Current Pharmaceutical Analysis","issn_l":"1573-4129","issn":["1573-4129","1875-676X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Analysis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W119632337","https://openalex.org/W893011145","https://openalex.org/W1629550224","https://openalex.org/W1964559497","https://openalex.org/W1966102963","https://openalex.org/W1968377879","https://openalex.org/W1970654744","https://openalex.org/W1971019889","https://openalex.org/W1974564801","https://openalex.org/W1975769073","https://openalex.org/W1976208663","https://openalex.org/W1977455540","https://openalex.org/W1979745166","https://openalex.org/W1983031743","https://openalex.org/W1986172579","https://openalex.org/W1990755599","https://openalex.org/W1990919818","https://openalex.org/W2014649829","https://openalex.org/W2015634686","https://openalex.org/W2018522840","https://openalex.org/W2021350512","https://openalex.org/W2027494848","https://openalex.org/W2031304611","https://openalex.org/W2045859283","https://openalex.org/W2048349218","https://openalex.org/W2051259474","https://openalex.org/W2054758126","https://openalex.org/W2070345949","https://openalex.org/W2074900191","https://openalex.org/W2088390812","https://openalex.org/W2088418822","https://openalex.org/W2090276833","https://openalex.org/W2092464508","https://openalex.org/W2093085493","https://openalex.org/W2113452381","https://openalex.org/W2137006877","https://openalex.org/W2179656444","https://openalex.org/W2186625564","https://openalex.org/W2200091984","https://openalex.org/W2301193853","https://openalex.org/W2301379914","https://openalex.org/W2322476314","https://openalex.org/W2323274179","https://openalex.org/W2339914158","https://openalex.org/W2473696700","https://openalex.org/W2525066034","https://openalex.org/W2621022158","https://openalex.org/W2898947404","https://openalex.org/W2912933166","https://openalex.org/W2914150312","https://openalex.org/W2936940612","https://openalex.org/W3004465995","https://openalex.org/W3039717648","https://openalex.org/W3044354852","https://openalex.org/W3194907831","https://openalex.org/W4247866228","https://openalex.org/W4367692818","https://openalex.org/W4394910097","https://openalex.org/W6635815491"],"related_works":["https://openalex.org/W2756163704","https://openalex.org/W1629550224","https://openalex.org/W1974564801","https://openalex.org/W4214729346","https://openalex.org/W3119668716","https://openalex.org/W4387653258","https://openalex.org/W4413194508","https://openalex.org/W4225784314","https://openalex.org/W4206782696","https://openalex.org/W2525066034"],"abstract_inverted_index":{"This":[0,82],"review":[1,54],"looks":[2],"at":[3],"the":[4,35,69,91,132,162,179],"latest":[5],"developments":[6],"in":[7,34,38],"some":[8],"analytical":[9,92,110,180],"techniques":[10,181],"employed":[11],"for":[12,19,76],"impurity":[13,51,107,133],"profiling":[14,134],"and":[15,50,63,79,104,156,171],"forced":[16,101],"degradation":[17,102],"studies":[18,103],"sartans,":[20],"or":[21],"angiotensin":[22,105,136],"(AT1)":[23],"receptor":[24,137],"blockers,":[25],"which":[26],"are":[27,74,95],"widely":[28,165],"used":[29,98,166,185],"to":[30,61,85,99,130,153,188],"treat":[31],"hypertension.":[32],"Interest":[33],"impurities":[36,59,192],"found":[37],"APIs":[39],"is":[40],"constantly":[41],"growing.":[42],"Several":[43],"regulatory":[44],"bodies":[45],"now":[46],"require":[47],"both":[48],"purity":[49],"profiles.":[52],"The":[53],"also":[55],"gives":[56],"overview":[57,89],"of":[58,90,135,161,178],"relevant":[60],"products":[62],"manufacturing":[64],"processes,":[65],"as":[66,68,123,125,146,173,175],"well":[67,124,174],"minimal":[70],"concentration":[71],"values":[72],"that":[73,94,182],"allowed":[75],"elemental,":[77],"inorganic,":[78],"organic":[80],"impurities.":[81],"study":[83],"aims":[84],"give":[86],"a":[87,176],"general":[88],"methods":[93],"currently":[96],"being":[97],"evaluate":[100,131],"blocker":[106,138],"profiling.":[108],"Diverse":[109],"methods,":[111],"including":[112,168],"UHPLC-MS/MS,":[113],"LC-FD,":[114],"UV-diode":[115],"array":[116],"detector,":[117],"HPLC":[118,147],"NMR,":[119],"Supercritical":[120],"fluid":[121],"extraction,":[122],"FT-IR,":[126],"have":[127,183,193],"been":[128,184,194],"utilized":[129],"drugs":[139],"with":[140,149],"realistic":[141],"retention":[142],"lengths.":[143],"Methods":[144],"such":[145],"coupled":[148],"MS/MS":[150],"were":[151],"developed":[152],"lower":[154],"detection":[155],"quantification":[157],"limitations.":[158],"In-depth":[159],"explanations":[160],"three":[163],"most":[164],"sartans":[167],"losartan,":[169],"valsartan,":[170],"olmesartan":[172],"summary":[177],"so":[186],"far":[187],"distinguish":[189],"degradants":[190],"from":[191],"included.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-02-26T00:00:00"}